Neuroblastoma classification: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) |
||
| Line 11: | Line 11: | ||
{{familytree | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">''' Neuroblastic tumors'''</div>}} | {{familytree | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">''' Neuroblastic tumors'''</div>}} | ||
{{familytree | | |,|-|^|-|.| | | | | | | | }} | {{familytree | | |,|-|^|-|.| | | | | | | | }} | ||
{{familytree | | X01 | | X02 | | | | | | |X01='''Schwannian stroma poor group'''| X02='''Schwannian stroma rich/dominant group'''}} | {{familytree | | X01 | | X02 | | | | | | |X01='''Schwannian stroma-poor group'''| X02='''Schwannian stroma-rich/dominant group'''}} | ||
{{familytree|boxstyle= border-top: 0px;| | A01 | | A03 | | | | | | |A01=<div style="width: 20em; padding:1em;"> | {{familytree|boxstyle= border-top: 0px;| | A01 | | A03 | | | | | | |A01=<div style="width: 20em; padding:1em;"> | ||
'''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;">|A03=<div style="width: 20em; padding:1em;"> | '''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;">|A03=<div style="width: 20em; padding:1em;"> | ||
Revision as of 13:43, 28 October 2015
|
Neuroblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neuroblastoma classification On the Web |
|
American Roentgen Ray Society Images of Neuroblastoma classification |
|
Risk calculators and risk factors for Neuroblastoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
- Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: a schwannian stroma-rich group and a schwannian stroma-poor group.[1][2][3]
Classification
- Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: a schwannian stroma-rich group and a schwannian stroma-poor group as illustrated below:[1][2][3]
Neuroblastic tumors | |||||||||||||||||||||||||||||
| Schwannian stroma-poor group | Schwannian stroma-rich/dominant group | ||||||||||||||||||||||||||||
Undifferentiated neuroblastoma Poorly differentiated neuroblastoma Differentiating neuroblastoma |
Nodular ganglioneuroblastoma Intermixed ganglioneuroblastoma Maturing ganglioneuroma Mature ganglioneuroma | ||||||||||||||||||||||||||||
References
- ↑ 1.0 1.1 Neuroblastoma. Libre Pathology (2015) http://librepathology.org/wiki/index.php/Adrenal_gland#Neuroblastoma Accessed on October, 5 2015
- ↑ 2.0 2.1 Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria (2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
- ↑ 3.0 3.1 Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.